Pharmaceuticals News and Research

RSS
Scientists decode key molecular gateway for toxin that causes botulism

Scientists decode key molecular gateway for toxin that causes botulism

NPC recalls Albuterol Sulfate Inhalation Solution

NPC recalls Albuterol Sulfate Inhalation Solution

Sanofi's Nasacort Allergy 24HR nasal spray receives FDA approval for over-the-counter use

Sanofi's Nasacort Allergy 24HR nasal spray receives FDA approval for over-the-counter use

Auxilium Pharmaceuticals gets exclusive right to market VIVUS's STENDRA in the US and Canada

Auxilium Pharmaceuticals gets exclusive right to market VIVUS's STENDRA in the US and Canada

New database tracks academic medial centers' policies on physician-industry ties

New database tracks academic medial centers' policies on physician-industry ties

FDA accepts, files Genentech's sBLA for subcutaneous use of Xolair in people with CIU

FDA accepts, files Genentech's sBLA for subcutaneous use of Xolair in people with CIU

Important information on effects, side effects of drugs is missing in most publications, says study

Important information on effects, side effects of drugs is missing in most publications, says study

Constellation Pharmaceuticals awarded grant to facilitate study of epigenetic control of inflammation

Constellation Pharmaceuticals awarded grant to facilitate study of epigenetic control of inflammation

Heptares' StaR platform offers breakthrough solution to challenge associated with antibodies therapeutics

Heptares' StaR platform offers breakthrough solution to challenge associated with antibodies therapeutics

Chemists discover mystery of how organic crystals form

Chemists discover mystery of how organic crystals form

Lundbeck, Otsuka to continue development of Lu AE58054 compound for Alzheimer's disease

Lundbeck, Otsuka to continue development of Lu AE58054 compound for Alzheimer's disease

Adempas drug gets FDA approval for treatment of pulmonary hypertension

Adempas drug gets FDA approval for treatment of pulmonary hypertension

Study proposes novel treatment for narcolepsy

Study proposes novel treatment for narcolepsy

Key findings may have broad implications for future scleroderma therapy

Key findings may have broad implications for future scleroderma therapy

Allegro receives FDA IND approval to initiate Phase II clinical studies of ALG-1001 in AMD, VMT patients

Allegro receives FDA IND approval to initiate Phase II clinical studies of ALG-1001 in AMD, VMT patients

Lakewood-Amedex, Wainwright enter into strategic advisory agreement

Lakewood-Amedex, Wainwright enter into strategic advisory agreement

First Edition: September 9, 2013

First Edition: September 9, 2013

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.